Cited 0 time in
Screening Sarcopenia in Rural Community-Dwelling Older Adults in Korea
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 김미경 | - |
| dc.contributor.author | 이지연 | - |
| dc.contributor.author | 길초롱 | - |
| dc.contributor.author | 김보람 | - |
| dc.contributor.author | 장희경 | - |
| dc.date.accessioned | 2022-12-26T13:31:00Z | - |
| dc.date.available | 2022-12-26T13:31:00Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.issn | 2288-7202 | - |
| dc.identifier.issn | 2288-7318 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/7424 | - |
| dc.description.abstract | Several screening tools have been developed to identify sarcopenia in rural community-dwelling older adults. We aimed to compare the diagnostic accuracy of two such tools, namely the SARC-F and SARCCalF assessments. Methods: This cross-sectional study on 388 community-dwelling older adults comprised 254 women and 134 men with a mean age of 77.8 ± 6.26 year in Korea. We assessed muscle mass, muscle strength, and physical performance using a bioimpedance analysis device, hydraulic hand dynamometer, and 4 m gait speed test, respectively. Three widely-used diagnostic criteria [the Asian Working Group for Sarcopenia (AWGS), European Working Group on Sarcopenia in Older People, and the International Working Group on Sarcopenia] were applied. Sensitivity and specificity analyses were performed on the SARC-CalF and SARC-F tests. We used receiver-operating characteristic curves and the area under the curves (AUCs) to compare the diagnostic accuracy of the assessments with regard to sarcopenia. Results: An analysis using four sets of diagnostic criteria showed that the prevalence of sarcopenia was 27.6% to 41.0%. Using the AWGS 2019 criteria as a reference standard, the SARC-CalF had a sensitivity of 83.02% and a specificity of 53.71% in the entire study population, whereas the SARC-F had a sensitivity of 79.87% and a specificity of 41.92%. The AUCs for the SARC-CalF and SARC-F tests were 0.725 (95% confidence interval 0.678‒0.769) and 0.645 (95% confidence interval 0.595‒0.693), respectively (p<001). In the analyses using the other three diagnostic criteria, similarity was also confirmed. Conclusion: SARC-CalF showed better sensitivity than did SARC-F when diagnosing sarcopenia in rural community-dwelling older adults. Further studies are needed to verify this finding in different populations. | - |
| dc.format.extent | 12 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | 국제문화기술진흥원 | - |
| dc.title | Screening Sarcopenia in Rural Community-Dwelling Older Adults in Korea | - |
| dc.title.alternative | Screening Sarcopenia in Rural Community-Dwelling Older Adults in Korea | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.bibliographicCitation | The International Journal of Advanced Culture Technology, v.8, no.4, pp 64 - 75 | - |
| dc.citation.title | The International Journal of Advanced Culture Technology | - |
| dc.citation.volume | 8 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 64 | - |
| dc.citation.endPage | 75 | - |
| dc.identifier.kciid | ART002667408 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.subject.keywordAuthor | Older adults | - |
| dc.subject.keywordAuthor | Sarcopenia | - |
| dc.subject.keywordAuthor | Screening | - |
| dc.subject.keywordAuthor | Sensitivity | - |
| dc.subject.keywordAuthor | Specificity | - |
| dc.subject.keywordAuthor | Validation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
